|
Report Date : |
22.01.2014 |
IDENTIFICATION DETAILS
|
Name : |
MEDICAL BIOMATERIAL AND PHARMACEUTICAL CO LTD |
|
|
|
|
Formerly Known As : |
XI NGHIEP DUOC PHAM VA SINH HOC Y TE XINGHIEP VAT LIEU SINH HOC MEBIFAC |
|
|
|
|
Registered Office : |
31 Ngo
Thoi Nhiem St Ward 6, District 3, Ho Chi Minh |
|
|
|
|
Country : |
Vietnam |
|
|
|
|
Date of Incorporation : |
07.03.2007 |
|
|
|
|
Legal Form : |
Company Limited |
|
|
|
|
Line of Business : |
Manufacturer of Medical Equipment and Pharmaceutical |
|
|
|
|
No of Employees : |
280 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2013
|
Country Name |
Previous Rating (30.06.2013) |
Current Rating (30.09.2013) |
|
Vietnam |
B1 |
B1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
VIETNAM - ECONOMIC OVERVIEW
Vietnam is a densely-populated
developing country that has been transitioning from the rigidities of a
centrally-planned economy since 1986. Vietnamese authorities have reaffirmed
their commitment to economic modernization in recent years. Vietnam joined the
World Trade Organization in January 2007, which has promoted more competitive,
export-driven industries. Vietnam became an official negotiating partner in the
Trans-Pacific Partnership trade agreement in 2010. Agriculture's share of
economic output has continued to shrink from about 25% in 2000 to less than 22%
in 2012, while industry's share increased from 36% to nearly 41% in the same
period. State-owned enterprises account for roughly 40% of GDP. Poverty has
declined significantly, and Vietnam is working to create jobs to meet the
challenge of a labor force that is growing by more than one million people
every year. The global recession hurt Vietnam's export-oriented economy, with
GDP in 2012 growing at 5%, the slowest rate of growth since 1999. In 2012,
however, exports increased by more than 18%, year-on-year; several
administrative actions brought the trade deficit back into balance. Between
2008 and 2011, Vietnam's managed currency, the dong, was devalued in excess of
20%, but its value remained stable in 2012. Foreign direct investment inflows
fell 4.5% to $10.5 billion in 2012. Foreign donors have pledged $6.5 billion in
new development assistance for 2013. Hanoi has oscillated between promoting
growth and emphasizing macroeconomic stability in recent years. In February
2011, the government shifted from policies aimed at achieving a high rate of
economic growth, which had stoked inflation, to those aimed at stabilizing the
economy, through tighter monetary and fiscal control. Although Vietnam unveiled
a broad, "three pillar" economic reform program in early 2012,
proposing the restructuring of public investment, state-owned enterprises, and
the banking sector, little perceptible progress had been made by early 2013. Vietnam's
economy continues to face challenges from an undercapitalized banking sector.
Non-performing loans weigh heavily on banks and businesses. In September 2012,
the official bad debt ratio climbed to 8.8%, though some independent analysts
believe it could be higher than 15%.
|
Source
: CIA |
Company Details
|
Organization Name |
: |
MEDICAL BIOMATERIAL AND PHARMACEUTICAL CO LTD |
|
Address |
: |
31 Ngo Thoi Nhiem St Ward 6, District 3, Ho Chi Minh |
|
Country |
: |
Vietnam |
|
Phone (S) |
: |
[+84] 8-38156101 |
|
Facsimile |
: |
[+84] 8-38155683 |
|
Email |
: |
|
|
Website |
: |
|
|
Primary Business Activity |
: |
Manufacturer |
|
Key Industry |
: |
Medical Equipment & Pharmaceutical |
|
Registered Legal Address |
: |
31 Ngo Thoi Nhiem St Ward 6, District 3, Ho Chi Minh |
||||||||
|
Operational Address |
: |
31 Ngo Thoi Nhiem St Ward 6, District 3, Ho Chi Minh |
||||||||
|
Trading Name |
: |
MEBIPHAR |
||||||||
|
Name History |
: |
|
||||||||
|
Issuing Authority |
: |
Dept. of Planning & Investment - Ho Chi Minh |
||||||||
|
License Number |
: |
0300533351 |
||||||||
|
License Status |
: |
License exists - Normal. |
||||||||
|
Legal Form - Category |
: |
Joint Stock Company |
||||||||
|
Legal Form |
: |
Company Limited |
||||||||
|
Legal Form - Abbreviation |
: |
CO LTD |
||||||||
|
Operational Status of Business |
: |
Normal |
||||||||
|
Date of Registration |
: |
7 Mar, 2007 |
||||||||
|
Employees |
: |
280 |
||||||||
|
Capital |
: |
US$ 1,707,125 |
|
Country |
: |
Vietnam |
|
Business Entity Name |
: |
MEDICAL BIOMATERIAL AND PHARMACEUTICAL CO LTD |
|
Primary Business Activity |
: |
Manufacturer |
|
Primary Industry |
: |
Medical Equipment & Pharmaceutical |
|
Office Contact
Details |
||
|
Operating Address |
: |
31 Ngo Thoi Nhiem St Ward 6, District 3, Ho Chi Minh |
|
Tel |
: |
[+84] 8-38156101 |
|
|
: |
[+84] 8-39303894 |
|
|
: |
[+84] 8-38150974 |
|
Fax |
: |
[+84] 8-38155683 |
|
Email |
: |
|
|
Website Details |
||
|
Website |
: |
|
|
Status |
: |
Normal - operational |
|
Country of Registration |
: |
Vietnam |
|
Ownership Type |
: |
Registered ownership by Subject Business Entity |
|
|
COMPANY
MANAGEMENT |
||||||||||||||||||||
|
|
|
||||||||||||||||||||
|
|
Management
Listings |
||||||||||||||||||||
|
|
|
||||||||||||||||||||
|
|
|||||||||||||||||||||
|
|
|
||||||||||||||||||||
|
|
|||||||||||||||||||||
|
|
|
||||||||||||||||||||
|
|
|||||||||||||||||||||
|
|
|
||||||||||||||||||||
|
|
COMPANY
DIRECTORS |
|||||||||||||||
|
|
|
|
|
REPUTATION |
|
|
Reference checking for the purpose of establishing the MEDICAL BIOMATERIAL
AND PHARMACEUTICAL CO LTD's reputation within the respective industry failed
to reveal any adverse information. |
|
|
NEGA-SCAN - ADVERSE DATA MONITORING |
|
|
|
|
|
CAPITAL (Currency: VND - Vietnam Dong) |
|||
|
|
|
|
|
SHAREHOLDERS |
||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||
|
|
PAYMENT TERMS |
||||||||||
|
|
Selling |
||||||||||
|
|
|
||||||||||
|
|
Purchasing |
||||||||||
|
|
|
Na
FINANCIAL
STATEMENT - DETAILED
Based on the corporate
laws of Vietnam, legal entities which are Joint Stock Company are not required
to make public disclosure of their annual financials. Therefore no financials
are available for this entity.
Na
Primary Products
|
Products / Materials / Services Description |
Activity |
|
Medical equipment |
Manufacturing |
|
Pharmaceutical equipment |
Manufacturing |
|
|
SIC PRODUCT
CLASSIFICATION & ACTIVITY |
|||||||||
|
|
|
|||||||||
|
|
|
|
|
|
||||||||||||
|
|
HARMONIZED
PRODUCT CLASSIFICATION & ACTIVITY |
||||||||||||
|
|
|
||||||||||||
|
|
|
Core Business
The primary business focus of MEDICAL BIOMATERIAL AND PHARMACEUTICAL CO
LTD is Manufacturing - Finished products.
Key products include :
An integral part of the core business includes:
·
Distribution
Supplementary Business
In addition to the core business, MEDICAL BIOMATERIAL AND PHARMACEUTICAL
CO LTD also is engaged in the following areas of business:
·
Importing - Raw materials
|
Annual Sales Analysis |
Percentage |
|
Domestic Sales |
100% |
|
International Sales (Export) |
0% |
|
Annual Purchases Analysis |
Percentage |
|
Local Purchases |
20% |
|
Imports |
80% |
|
Bank Name |
: |
ASIA COMMERCIAL BANK |
|
Global Identifier |
: |
P0075118 |
|
Branch |
: |
District 3,Ho Chi Minh |
|
Branch Address |
: |
ASIA COMMERCIAL BANK - HO CHI MINH |
|
SWIFT Code |
: |
ASCBVNVX |
|
Branch |
: |
MEDICAL BIOMATERIAL AND PHARMACEUTICAL CO LTD - TAN PHU DIST, HO CHI
MINH |
|
Branch Address |
: |
Lot III 18 Rd 3 Tan Binh Induatrial Zone, Tan Phu Dist, Ho Chi Minh |
Activity &
Markets
|
Country / Region |
Estimated level
of importance |
Trading Activity |
|
Asia / Pacific |
Medium |
Importing |
|
Europe |
Medium |
Importing |
|
North America |
Medium |
Importing |
|
China |
Medium |
Importing |
|
France |
Medium |
Importing |
|
Germany |
Medium |
Importing |
|
India |
Medium |
Importing |
|
Japan |
Medium |
Importing |
|
Korea, South (Republic of Korea) |
Medium |
Importing |
|
Malaysia |
Medium |
Importing |
|
Singapore |
Medium |
Importing |
|
USA |
Medium |
Importing |
|
Name |
: |
MEDICAL BIOMATERIAL AND PHARMACEUTICAL CO LTD - DISTRICT 3, HO CHI
MINH |
|
Address |
: |
31 Ngo Thoi Nhiem St Ward 6, District 3, Ho Chi Minh |
|
Country |
: |
Vietnam |
|
Status |
: |
Operational |
|
Date |
Details |
|
1988 |
Established as government enterprise. |
|
2007 - Mar |
Changed formation to limited liability company. |
|
License Date |
License No. |
|
27 Mar, 1993 |
102484 |
|
22 Aug, 2006 |
4106000271 |
Na
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs. 61.53 |
|
|
1 |
Rs. 101.08 |
|
Euro |
1 |
Rs. 83.37 |
INFORMATION DETAILS
|
Report Prepared
by : |
DPT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.